NBC
IDXX icon

Neuberger Berman Canada’s Idexx Laboratories IDXX Stock Holding History

Neuberger Berman Canada’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$872K Sell
5,611
-637
-10% -$101K 0.16% 175
2017
Q2 		$1.01M Sell
6,248
-475
-7% -$77.1K 0.19% 140
2017
Q1 		$1.04M Buy
6,723
+4,597
+216% +$634K 0.2% 139
2016
Q4 		$249K Buy
+2,126
New +$243K 0.06% 227

Other funds holding IDXX

Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Neuberger Berman Canada's IDXX Position: Q3 2017 in Review

Neuberger Berman Canada reduced its Idexx Laboratories (IDXX) stake by 10% in Q3 2017, selling an estimated $101K and leaving 5,611 shares worth $872K. The position accounts for 0.16% of the portfolio, ranked #175.

Neuberger Berman Canada first reported a position in IDXX in Q4 2016 and has held it in 4 quarters since. The position peaked at $1.04M in Q1 2017. 573 funds tracked by Wall St. Rank hold IDXX as of Q3 2017.

  • Neuberger Berman Canada held 5,611 shares of Idexx Laboratories worth $872K as of Q3 2017.
  • Neuberger Berman Canada sold 637 Idexx Laboratories shares in Q3 2017, an estimated $101K.
  • Idexx Laboratories made up 0.16% of Neuberger Berman Canada's portfolio in Q3 2017, its #175 holding.
  • Neuberger Berman Canada first reported a position in Idexx Laboratories in Q4 2016 and has held it in 4 quarters since.
  • Neuberger Berman Canada's Idexx Laboratories position peaked at $1.04M in Q1 2017.
  • 573 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2017.

Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.